1-7 of 7
Michael T. Hemmer, MS
Close
Sort by
Journal Articles

Early Broad-Spectrum Antibiotics and Risk of Acute Graft-Versus-Host Disease in Children: An Analysis from the Center for International Blood and Marrow Transplantation Research (CIBMTR) and the Pediatric Health Information System (PHIS)

Caitlin W Elgarten, MD MSc, Yimei Li, PhD, Yuan-Shung V. Huang, MS, Richard Aplenc, MD PhD, Michael T. Hemmer, MS, Mukta Arora, MD, Stephen R. Spellman, MS, Tao Wang, PhD, Madan Jagasia, MBBS, MS, MMHC, Margaret L. MacMillan, MD, Joseph Pidala, MD, Brian T. Fisher, DO, MSCE, Matt Hall, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 599.
https://doi.org/10.1182/blood-2019-130466
Published: 2019
Journal Articles

Impact of T-Cell Dose on Gvhd Risk after Allogeneic HLA-Matched PBSC Transplantation

Ayman Saad, MD, Tao Wang, PhD, Michael T. Hemmer, MS, Stephen R. Spellman, Mukta Arora, MD, Lawrence S. Lamb, Jr., PhD, Shahrukh K. Hashmi, MD MPH
Journal: Blood
Blood (2018) 132 (Supplement 1): 3410.
https://doi.org/10.1182/blood-2018-99-113513
Published: 2018
Journal Articles

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome: Effect of Transplant Conditioning Regimen Intensity on Outcomes

Mary Eapen, MBBS, MS, Ruta Brazauskas, PhD, Michael T. Hemmer, MS, Waleska S Pérez, MPH, Patricia Steinart, PhD, Mary M. Horowitz, MD MS, H. Joachim Deeg, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 598.
https://doi.org/10.1182/blood.V130.Suppl_1.598.598
Published: 2017
Journal Articles

Graft-Versus-Host Disease (GVHD)-Free Relapse-Free Survival (GRFS) and Chronic Gvhd (CRFS) in Alternative Donor Hematopoietic Cell Transplantation (HCT) in Pediatric Patients

Rohtesh S. Mehta, MDMPH,MS, Shernan G. Holtan, MD, Tao Wang, PhD, Michael T. Hemmer, MS, Stephen R. Spellman, Mukta Arora, MD, Daniel R. Couriel, MD, Amin M. Alousi, Joseph Pidala, MD PhD, Daniel J. Weisdorf, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2053.
https://doi.org/10.1182/blood.V130.Suppl_1.2053.2053
Published: 2017
Journal Articles

Graft-Versus-Host Disease (GVHD)-Free Relapse-Free Survival (GRFS) and Chronic Gvhd (CRFS) in Alternative Donor Hematopoietic Cell Transplantation (HCT) in Adults

Rohtesh S. Mehta, MDMPH,MS, Shernan G. Holtan, MD, Tao Wang, PhD, Michael T. Hemmer, MS, Stephen R. Spellman, Mukta Arora, MD, Daniel R. Couriel, MD, Amin M. Alousi, Joseph Pidala, MD PhD, Daniel J. Weisdorf, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 517.
https://doi.org/10.1182/blood.V130.Suppl_1.517.517
Published: 2017
Journal Articles

Comparison of Tacrolimus Versus Cyclosporine with Methotrexate for Immunosuppression after Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia: A CIBMTR Analysis

Yoshihiro Inamoto, MD PhD, Paul J. Martin, MD, Mary E. Flowers, MD, Alvaro Urbano-Ispizua, MD, Tao Wang, PhD, Michael T. Hemmer, MS, Corey S Cutler, MD MPH, Daniel R. Couriel, MD, Amin M. Alousi, MD, Mukta Arora, MD MS, Stephen R. Spellman, MBS
Journal: Blood
Blood (2014) 124 (21): 4383.
https://doi.org/10.1182/blood.V124.21.4383.4383
Published: 2014
Journal Articles

The CIBMTR Chronic GVHD Risk Group Predicts Major Outcomes In An Independent Validation Cohort

Mary E. D. Flowers, MD, John P. Klein, PhD, Michael T. Hemmer, MS, Peigang Li, MS, Corey S. Cutler, MD, Alvaro Urbano-Ispizua, MD, Daniel R. Couriel, MD, Robert Peter Gale, MD, PhD, DSc, FACP, Yoshihiro Inamoto, MD, PhD, Joseph H. Antin, MD, Brian J. Bolwell, MD, Michael Boyiadzis, MD, MHSc, Jean-Yves Cahn, MD, Mitchell S. Cairo, MD, Luis M. Isola, MD, David A. Jacobsohn, MD, Madan Jagasia, MBBS, MS, Thomas R. Klumpp, MD, Effie W. Petersdorf, MD, Stella Santarone, MD, Harry C. Schouten, MD, PhD, John R. Wingard, MD, PhD, Stephen Spellman, MBS, Daniel J. Weisdorf, MD, Steven Z. Pavletic, MD, Stephanie J. Lee, MD, MPH, Mary M. Horowitz, MD, MS, Mukta Arora, MD, MS
Journal: Blood
Blood (2013) 122 (21): 706.
https://doi.org/10.1182/blood.V122.21.706.706
Published: 2013